|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 334.50 EUR | -4.43% |
|
+2.45% | -6.43% |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 | ![]() |
| 07-21 | Despite the escalation in the Middle East, European stocks stay the course |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 17.17x | 2.3x | 1.3x | 1.97x | 9.71x | 12.04x | 0.49% | 3.35B | ||
| 11.61x | 7.81x | 1.88x | 3.88x | 8.86x | 10.02x | 2.9% | 31.1B | ||
| 258.57x | 1.95x | -2.14x | 3.09x | 15.6x | 18.08x | -.--% | 12.66B | ||
| 7.52x | 1.1x | 0.05x | 1.07x | 3.98x | 5.21x | 3.49% | 3.72B | ||
| 47.8x | 2.25x | 0.29x | - | - | - | 0.75% | 1.82B | ||
| 35.47x | 2.16x | 0.8x | 3.84x | 13.7x | 19.83x | -.--% | 1.86B | ||
| 13.66x | 3.63x | 0.13x | 1.28x | 7.62x | 9.03x | 1.41% | 1.37B | ||
| 16.31x | 1.48x | 1.52x | 2.06x | 9.49x | 14.67x | 1.88% | 1.07B | ||
| 32.1x | 1.12x | 1.67x | - | - | - | 0.47% | 968M | ||
| 15.14x | 1.26x | -3.65x | 1.08x | 5.11x | 7.24x | 1.29% | 951M | ||
| 12.46x | 1.33x | 1.02x | - | - | - | - | 862M | ||
| 17.97x | 1.94x | -1.43x | - | - | - | 1.13% | 605M | ||
| 20.36x | 1.35x | -2.75x | - | - | - | - | 514M | ||
| 22.82x | 0.52x | 0.13x | 1.72x | 8.26x | 16.91x | 1.98% | 367M | ||
| 65.39x | 2.03x | -2.17x | 2.56x | 14.24x | 18.66x | 1.65% | 308M | ||
| Average | 39.62x | 2.15x | -0.22x | 2.26x | 9.66x | 13.17x | 1.34% | 4.1B | |
| Weighted average by Cap. | 65.26x | 4.88x | 0.59x | 3.24x | 10.20x | 12.05x | 1.89% |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions

















